Nanologica AB Market Cap ($5.75 Million)
Market Cap & Net Worth: Nanologica AB (NICA)
Nanologica AB market cap. Nanologica AB (ST:NICA) has a market capitalization of $5.75 Million (Skr53.43 Million) as of November 5, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #28216 globally and #619 in its home market, demonstrating a 0.31% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nanologica AB's stock price Skr0.16 by its total outstanding shares 328769842 (328.77 Million). Also see how efficiently does Nanologica AB generate cash for how efficiently the company converts equity into cash flow.
Nanologica AB Market Cap History (2017–2026)
Nanologica AB market cap history from 2017 to 2026. Data shows change from $304.97 Million to $5.75 Million (-37.54% CAGR). Check NICA live share price for real-time trading data and today's change.
Nanologica AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nanologica AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore NICA net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.31x
Nanologica AB's market cap is 1.31 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $304.97 Million | $2.60 Million | -$20.10 Million | 117.30x | N/A |
| 2018 | $112.37 Million | $4.15 Million | -$20.89 Million | 27.11x | N/A |
| 2019 | $371.04 Million | $10.23 Million | -$21.47 Million | 36.28x | N/A |
| 2020 | $474.10 Million | $16.14 Million | -$24.83 Million | 29.38x | N/A |
| 2021 | $484.72 Million | $12.91 Million | -$50.13 Million | 37.53x | N/A |
| 2022 | $353.81 Million | $1.55 Million | -$55.09 Million | 227.53x | N/A |
| 2023 | $367.96 Million | $1.44 Million | -$75.16 Million | 255.00x | N/A |
| 2024 | $64.39 Million | $14.54 Million | -$65.63 Million | 4.43x | N/A |
| 2025 | $27.60 Million | $21.13 Million | -$51.29 Million | 1.31x | N/A |
Competitor Companies of NICA by Market Capitalization
Companies near Nanologica AB in the global market cap rankings as of November 5, 2026. Also see Nanologica AB total assets for a full breakdown of the balance sheet.
Key companies related to Nanologica AB by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #181 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #373 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #415 globally with a market cap of $67.74 Billion USD ( AU$95.74 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #503 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #181 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $549.04 |
| #373 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $930.67 |
| #415 | CSL Ltd | AU:CSL | $67.74 Billion | AU$197.34 |
| #503 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $258.38 |
Market Capitalization of Nanologica AB (2017–2026)
Market capitalization of Nanologica AB from 2017 to today. Between 2017 and today, Nanologica AB's market cap moved from $304.97 Million to $ 5.75 Million, with a yearly change of -37.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr5.75 Million | -79.17% |
| 2025 | Skr27.60 Million | -57.14% |
| 2024 | Skr64.39 Million | -82.50% |
| 2023 | Skr367.96 Million | +4.00% |
| 2022 | Skr353.81 Million | -27.01% |
| 2021 | Skr484.72 Million | +2.24% |
| 2020 | Skr474.10 Million | +27.78% |
| 2019 | Skr371.04 Million | +230.19% |
| 2018 | Skr112.37 Million | -63.15% |
| 2017 | Skr304.97 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Nanologica AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.75 Million USD |
| MoneyControl | $5.75 Million USD |
| MarketWatch | $5.75 Million USD |
| marketcap.company | $5.75 Million USD |
| Reuters | $5.75 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Nanologica AB
Nanologica AB (publ), a life science tools company, develops, manufactures, and sells nanoporous silica particles in China, India, Turkey, the United States, and internationally. The company offers NLAB Saga, a silica-based purification media for preparative chromatography that is developed for the purification of peptide drugs, such as insulin and GLP-1 analogues; NLAB Idun, an ion exchange prod… Read more